Oncotarget

Vol 10, No 60

November 5, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 60 of Oncotarget features Figure 3, "Comparison of cytokine levels grouped by function," by Donnenberg, et al.

Table of Contents

Editorial

Breathing the air of mitochondrial respiration via an important oncotarget - mitochondrial glycerophosphate dehydrogenase (mGPDH)

Breathing the air of mitochondrial respiration via an important oncotarget - mitochondrial glycerophosphate dehydrogenase (mGPDH)

https://doi.org/10.18632/oncotarget.27292

Shilpa Thakur,  and Joanna Klubo-Gwiezdzinska
6400-6402
PDF  |  How to cite  |  Order a Reprint

Research Papers

Volasertib preclinical activity in high-risk hepatoblastoma

Volasertib preclinical activity in high-risk hepatoblastoma

https://doi.org/10.18632/oncotarget.27237

Dina Kats, Cora A. Ricker, Noah E. Berlow, Bénédicte Noblet, Delphine Nicolle, Katell Mevel, Sophie Branchereau, Jean-Gabriel Judde, Cody D. Stiverson, Christina L. Stiverson, Matthew N. Svalina, Teagan Settelmeyer, Kevin Matlock, Melvin Lathara, Charlotte Mussini, James I. Geller, Christopher Noakes, Ido Sloma, Narendra Bharathy, Stefano Cairo,  and Charles Keller
6403-6417
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Oxaliplatin-induced neuropathy: the preventive effect of a new super-oxide dismutase modulator

Oxaliplatin-induced neuropathy: the preventive effect of a new super-oxide dismutase modulator

https://doi.org/10.18632/oncotarget.27248

Marie-Anne Guillaumot, Olivier Cerles, Hélène C. Bertrand, Evelyne Benoit, Carole Nicco, Sandrine Chouzenoux, Alain Schmitt, Frédéric Batteux, Clotilde Policar,  and Romain Coriat
6418-6431
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes

The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes

https://doi.org/10.18632/oncotarget.27266

Francesca Coperchini, Laura Croce, Marco Denegri, Oriana Awwad, Samuel Tata Ngnitejeu, Flavia Magri, Luca Chiovato,  and Mario Rotondi
6432-6443
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Association between ANGPTL-4 and the proinflammatory process in cancer cachexia patients

Association between ANGPTL-4 and the proinflammatory process in cancer cachexia patients

https://doi.org/10.18632/oncotarget.27269

Nelson Inácio Pinto Neto, Valter Tadeu Boldarine, Ana Claudia Losinskas Hachul, Lila Missae Oyama, Joanna Darck Carola Correia Lima, Estefania Simoes Fernandez, José Pinhata Otoch, Paulo Sérgio Martins de Alcântara, Flavio Tokeshi, Marilia Cerqueira Leite Seelaender,  and Claudia Maria da Penha Oller do Nascimento
6444-6455
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant mesothelioma: therapeutic implications

Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant mesothelioma: therapeutic implications

https://doi.org/10.18632/oncotarget.27290

Albert D. Donnenberg, James D. Luketich,  and Vera S. Donnenberg
6456-6465
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence

Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence

https://doi.org/10.18632/oncotarget.27294

Wusheng Yan, Muhammad Jamal, Shyh-Han Tan, Yingjie Song, Denise Young, Yongmei Chen, Shilpa Katta, Kai Ying, Lakshmi Ravindranath, Tarah Woodle, Indu Kohaar, Jennifer Cullen, Jacob Kagan, Sudhir Srivastava, Albert Dobi, David G. McLeod, Inger L. Rosner, Isabell A. Sesterhenn, Alagarsamy Srinivasan, Shiv Srivastava,  and Gyorgy Petrovics
6466-6483
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Pre-surgical connectome features predict IDH status in diffuse gliomas

Pre-surgical connectome features predict IDH status in diffuse gliomas

https://doi.org/10.18632/oncotarget.27301

Shelli R. Kesler, Rebecca A. Harrison, Melissa L. Petersen, Vikram Rao, Hannah Dyson, Kristin Alfaro-Munoz, Shiao-Pei Weathers,  and John de Groot
6484-6493
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection

SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection

https://doi.org/10.18632/oncotarget.27303

Jolein Mijnes, Janina Tiedemann, Julian Eschenbruch, Janina Gasthaus, Sarah Bringezu, Dirk Bauerschlag, Nicolai Maass, Norbert Arnold, Jörg Weimer, Tobias Anzeneder, Peter A. Fasching, Matthias Rübner, Benjamin Bruno, Uwe Heindrichs, Jennifer Freres, Hanna Schulz, Ralf-Dieter Hilgers, Nadina Ortiz-Brüchle, Sonja von Serenyi, Ruth Knüchel, Vera Kloten,  and Edgar Dahl
6494-6508
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma

https://doi.org/10.18632/oncotarget.27305

Johannes Fänder, Heike Kielstein, Maximilian Büttner, Peter Koelblinger, Reinhard Dummer, Marcus Bauer, Diana Handke, Claudia Wickenhauser, Barbara Seliger,  and Simon Jasinski-Bergner
6509-6525
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study

https://doi.org/10.18632/oncotarget.27251

Sarina A. Piha-Paul, Matthew H. Taylor, Daniel Spitz, Lee Schwartzberg, J. Thaddeus Beck, Todd M. Bauer, Funda Meric-Bernstam, Das Purkayastha, Linda Karpiak, Sebastian Szpakowski,  and Fadi Braiteh
6526-6535
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy

Correction: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy

https://doi.org/10.18632/oncotarget.27297

Tsung-I Hsu, Ying-Jung Chen, Chia-Yang Hung, Yi-Chang Wang, Sin-Jin Lin, Wu-Chou Su, Ming-Derg Lai, Sang-Yong Kim, Qiang Wang, Keduo Qian, Masuo Goto, Yu Zhao, Yoshiki Kashiwada, Kuo-Hsiung Lee, Wen-Chang Chang,  and Jan-Jong Hung
6536-6537
Correction  |  PDF  |  How to cite

Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin

Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin

https://doi.org/10.18632/oncotarget.27298

Alice Gerges Geagea, Manfredi Rizzo, Abdo Jurjus, Francesco Cappello, Angelo Leone, Giovanni Tomasello, Céline Gracia, Sahar Al Kattar, Liliane Massaad-Massade,  and Assaad Eid
6538-6539
Correction  |  PDF  |  How to cite

Correction: TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT

Correction: TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT

https://doi.org/10.18632/oncotarget.27299

Xinxing Li, Shifeng Teng, Yanyan Zhang, Weigang Zhang, Xianwen Zhang, Kai Xu, Houshan Yao, Jun Yao, Haolu Wang, Xiaowen Liang,  and Zhiqian Hu
6540-6540
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC